![Deepa Pakianathan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Deepa Pakianathan
Directeur/Membre du Conseil chez
MEREO BIOPHARMA GROUP PLC
Fortune : 219 209 $ au 30/09/2026
Profil
Dr. Deepa R.
Pakianathan is an Independent Director at Freenome, Inc., an Independent Director at Palleon Pharmaceuticals, Inc., a Chief Executive Officer at Redd Pharmaceuticals, Inc., an Independent Non-Executive Director at Mereo BioPharma Group Plc, an Independent Director at Karyopharm Therapeutics, Inc., a Managing Partner at Delphi Ventures, Inc., an Executive Vice Chairman & Treasurer at San Francisco Conservatory of Music, a Managing Member at Delphi Management Partners VII LLC, a Managing Member at Delphi Management Partners VIII LLC and a Managing Member at Delphi Ventures III LP.
She is on the Board of Directors at Freenome, Inc., Palleon Pharmaceuticals, Inc., Mereo BioPharma Group Plc, Karyopharm Therapeutics, Inc. and San Francisco Conservatory of Music.
Dr. Pakianathan was previously employed as an Independent Director by FS Development Corp.
II, an Independent Director by FS Development Corp., an Independent Director by Theravance Biopharma, Inc., an Independent Director by Alder Biopharmaceuticals, Inc., a Lead Independent Director by Calithera Biosciences, Inc., an Independent Director by OncoMed Pharmaceuticals, Inc., an Independent Director by Alexza Pharmaceuticals, Inc., a Vice President by J.P.
Morgan & Co. Ltd., a Senior Biotechnology Banker by J.P.
Morgan Partners LLC, a Research Analyst by Genesis Merchant Group Securities LLC, and a Postdoctoral Scientist by Genentech, Inc. She also served on the board at PTC Therapeutics, Inc., NeurAxon, Inc., Relypsa, Inc., Phenomix Corp., Adiana, Inc., Antipodean Pharmaceuticals, Inc., Ilypsa, Inc., National Venture Capital Association and Proteolix, Inc. She received her undergraduate degree from the University of Mumbai, a graduate degree from the University of Mumbai, a graduate degree from the Advanced Centre for Treatment Research & Education in Cancer, a graduate degree from Wake Forest University and a doctorate degree from Wake Forest University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,01 % | 20/07/2026 | 13 918 ( 0,01 % ) | 219 209 $ | 30/09/2026 |
| 21/05/2026 | 0 ( -.--% ) | - $ | 30/09/2026 | |
| 26/03/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Postes actifs de Deepa Pakianathan
| Sociétés | Poste | Début |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/04/2013 |
| MEREO BIOPHARMA GROUP PLC | Directeur/Membre du Conseil | 23/04/2019 |
Delphi Ventures, Inc.
 Delphi Ventures, Inc. Investment ManagersFinance Delphi Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical devices & diagnostics, biotechnology and healthcare services companies. It provides financing for early stage capital requirements. | Private Equity Investor | 01/06/2001 |
Redd Pharmaceuticals, Inc. | Directeur Général | 01/09/2019 |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Directeur/Membre du Conseil | 04/12/2020 |
Delphi Ventures III LP
 Delphi Ventures III LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
Delphi Management Partners VII LLC | Corporate Officer/Principal | - |
Delphi Management Partners VIII LLC | Corporate Officer/Principal | - |
San Francisco Conservatory of Music
 San Francisco Conservatory of Music Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Anciens postes connus de Deepa Pakianathan
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Deepa Pakianathan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
32
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 32 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Delphi Ventures III LP
Delphi Ventures III LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
Adiana, Inc.
 Adiana, Inc. Medical SpecialtiesHealth Technology Develops contraceptive medical devices | Health Technology |
Antipodean Pharmaceuticals, Inc.
 Antipodean Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and provides pre clinical services | Health Technology |
J.P. Morgan Partners LLC
 J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners provides financing for growth capital, corporate acquisitions, LBOs, special situations and recapitalizations. The firm invests globally across a variety of sectors including consumer, media, energy, industrial, financial services, healthcare and technology | Finance |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genesis Merchant Group Securities LLC
 Genesis Merchant Group Securities LLC Investment Banks/BrokersFinance Provides security brokerage and dealer services | Finance |
J.P. Morgan & Co. Ltd.
 J.P. Morgan & Co. Ltd. Financial ConglomeratesFinance Provides investment banking and financial services | Finance |
San Francisco Conservatory of Music
San Francisco Conservatory of Music Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bio-pharmaceutical related products | Health Technology |
Delphi Ventures, Inc.
Delphi Ventures, Inc. Investment ManagersFinance Delphi Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical devices & diagnostics, biotechnology and healthcare services companies. It provides financing for early stage capital requirements. | Finance |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Delphi Management Partners VII LLC | |
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Delphi Management Partners VIII LLC | Finance |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Calithera Biosciences, Inc.
 Calithera Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics to control cancer and other diseases | Health Technology |
Advanced Centre for Treatment Research & Education in Cancer
 Advanced Centre for Treatment Research & Education in Cancer Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
 Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Health Technology |
FS Development Corp.
 FS Development Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
FS Development Corp. II
 FS Development Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
Redd Pharmaceuticals, Inc. |
